Request for clarification from Ruiter et al regarding 'Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study'. Reply to Carstensen B [letter]

2012-03-01

Additional Metadata
Keywords	Breast cancer, Cancer, Insulin, Insulin analogues, Insulin glargine
Persistent URL	doi.org/10.1007/s00125-011-2448-2, hdl.handle.net/1765/59250
Journal	Diabetologia: clinical and experimental diabetes and metabolism
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ruiter, R., Visser, L., & Stricker, B. (2012). Request for clarification from Ruiter et al regarding 'Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study'. Reply to Carstensen B [letter]. Diabetologia: clinical and experimental diabetes and metabolism, 55(3), 859–860. doi:10.1007/s00125-011-2448-2

Publication